DGAP-News: Eckert & Ziegler: Travel grant for young researchers in nuclear medicine

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Miscellaneous

19.02.2009 

Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

Berlin, 19 February 2009. The Eckert & Ziegler/EANM abstract award is
entering the second round. Up to 12th April 2009 young scientists can again
participate in the competition with their innovative works in the field of
nuclear medicine. Every year this travel grant is designed to support young
scientists and doctoral students who seek to present the results of their
work to larger audiences during the annual congress of the European
Association of Nuclear Medicine (EANM) in October 2009. The five travel
grants, each endowed with 1,000 EUR, will be offered by Eckert & Ziegler AG
(ISIN DE0005659700), one of the leading European manufacturers of isotope
products and the European Association of Nuclear Medicine (EANM). The award
winners will be selected in cooperation with EANM. The five winners will
receive their awards on 14th October 2009 during the EANM congress in
Barcelona.
'In presenting the Eckert & Ziegler/EANM abstract award we wish to
encourage young researchers to present their ideas to a wider audience and
to collaborate more in exchanging ideas with other researchers engaged in
the field of nuclear medicine. We hope that this will help to ensure that
the enormous progress which has been made in medical imaging can soon be
transformed into more precise, faster or cheaper methods of diagnosis and
therapy', explained Dr Andreas Eckert, Chairman of the Board at Eckert &
Ziegler.

The group sees considerable future potential in the further development of
nuclear medical diagnostic techniques, especially based on the more
widespread use of so-called hybrid cameras. These cameras combine different
image processes - including Positron Emission Topography (PET). The quality
and the information content of the images are taking on completely new
dimensions and are enabling the development of new treatments and
operational control processes.

Conditions for participation
All EANM members who are not older than 38 years of age at the time of
application are entitled to participate. The applications can be submitted
electronically via http://eanm09.eanm.org. Application deadline is 12th
April 2009.

Eckert & Ziegler
The Eckert & Ziegler Group, that achieved a turnover of approx. 70 million
EUR in 2008 with around 410 employees, is one of the world's largest
providers of isotope component technology for radiation therapy and nuclear
medicine. Eckert & Ziegler is supporting the greater use of hybrid systems
by expanding its production sites for radioactive contrast agents and by
developing automated synthesis modules in which scientists can produce new
diagnostic substances with the requisite pharmaceutical quality.

Eckert & Ziegler AG, Karolin Riehle, Public Relations
Robert-Rössle-Str. 10, D-13125 Berlin, Tel.: +49 (0) 30 / 941084-138,
Fax-112, E-Mail: karolin.riehle@ezag.de, www.ezag.de


DGAP 19.02.2009 
---------------------------------------------------------------------------
Language:     English
Issuer:       ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
              Robert-Rössle-Str. 10
              13125 Berlin
              Deutschland
Phone:        +49 (0)30 941 084-0
Fax:          +49 (0)30 941 084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700
WKN:          565970
Listed:       Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
              Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News                                     DGAP News-Service
---------------------------------------------------------------------------